Results 161 to 170 of about 6,461 (225)

Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics. [PDF]

Cell Death Dis
Sreeram I, Plans-Marin S, Cruz-Rodríguez M, Aliagas E, Palau-Gallinat D, Muñoz-Pinedo C, Nadal E.   +6 more
europepmc   +1 more source

Natural killer cells: gatekeepers of healthy aging in longevity medicine. [PDF]

Inflamm Regen
Yang JY, Tu DT, Liao JC, Lee OK.
europepmc   +1 more source

Mitochondrial priming in therapy-induced senescence: implications for CAR-T/NK immunosenolytic therapy. [PDF]

Front Immunol
Menendez JA, Lupu R, Martin-Castillo B, Sardanyés J, Alarcón T, Verdura S, Cuyàs E.   +6 more
europepmc   +1 more source

Senogenic-senolytic treatment strategies enhance tumor control and can improve survival in murine cancer models: a systematic review. [PDF]

BMC Cancer
Hamburger ECB, Brigato P, Rosenzweig DH, Haglund L.   +3 more
europepmc   +1 more source

Disproportionality Analysis of Hematologic Adverse Event Signals Associated with Venetoclax in Combination with Senescence-Inducing Chemotherapy. [PDF]

J Clin Med
Saleh T, Ramadan M, Alsoud A, Al Shboul S.   +3 more
europepmc   +1 more source

Senotherapeutics for metabolic disease and diabetic complications. [PDF]

J Intern Med
Palmer AK, Spinelli R, Prata LGL, Chaib S, Suda M, Tchkonia T, Smith U, Kirkland JL.   +7 more
europepmc   +1 more source